StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a research report report published on Saturday morning. The firm issued a hold rating on the stock.
Milestone Scientific Trading Down 7.7 %
Shares of NYSE:MLSS opened at $0.89 on Friday. The company has a 50 day moving average of $0.73 and a 200 day moving average of $0.67. The stock has a market cap of $68.73 million, a P/E ratio of -8.90 and a beta of 0.89. Milestone Scientific has a 12 month low of $0.52 and a 12 month high of $1.35.
Milestone Scientific (NYSE:MLSS – Get Free Report) last announced its quarterly earnings data on Wednesday, May 15th. The company reported ($0.02) EPS for the quarter. The business had revenue of $2.25 million during the quarter. Milestone Scientific had a negative net margin of 74.50% and a negative return on equity of 93.64%.
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Featured Stories
- Five stocks we like better than Milestone Scientific
- 3 Stocks to Consider Buying in October
- Tech Leader’s Stock Split: Is It the Right Time to Buy?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Could the Economy be Bottoming? Major Bank’s Earnings Say Yes
- Want to Profit on the Downtrend? Downtrends, Explained.
- Seize This Prime Stock Opportunity on Amazon Prime Days
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
